Showing results (951-960 of 5,692) with videos related to
Sort By:
Pageof 570
The Oncologist|June 3, 2008
Current management of medullary thyroid cancerRebecca S Sippel, Muthusamy Kunnimalaiyaan, Herbert ChenThe Oncologist|June 3, 2008
Molecular markers and the pathogenesis of adrenocortical cancerPatsy S H Soon, Kerrie L McDonald, Bruce G Robinson, et al.The Oncologist|August 31, 2019
Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results DatabaseGuru Subramanian Guru Murthy, Aniko Szabo, Mehdi Hamadani, et al.The Oncologist|January 29, 2021
Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric AdenocarcinomaPengfei Yu, Yusheng Wang, Yanfei Yu, et al.The Oncologist|January 29, 2021
Activity of Sorafenib Plus Capecitabine in Previously Treated Metastatic Colorectal CancerThomas J George, Alison M Ivey, Azka Ali, et al.The Oncologist|February 1, 2021
Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted TherapeuticsDenis L Jardim, Sherri Z Millis, Jeffrey S Ross, et al.The Oncologist|February 1, 2021
Implementing Historical Controls in Oncology TrialsOlivier Collignon, Anna Schritz, Riccardo Spezia, et al.The Oncologist|February 1, 2021
Safety of Direct Oral Anticoagulants in Central Nervous System MalignanciesAndrew W Swartz, Jan DrappatzThe Oncologist|January 19, 2021
Reconsidering Dexamethasone for Antiemesis when Combining Chemotherapy and ImmunotherapyTobias Janowitz, Sam Kleeman, Robert H VonderheideThe Oncologist|January 19, 2021
RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR-Containing Therapy Regimens in Metastatic Colorectal CancerAlexa B Schrock, Jessica K Lee, Jaideep Sandhu, et al.Pageof 570